Question

 

In the natural history of a disease define total preclinical phase, detectable pre-clinical phase and clinical phase. Suppose on 09 am on 25.01.2024 a disease A onset you biologically. Suppose a test of disease A can detect it exactly after the completion of 30 days of biological onset. Suppose signs and symptoms develop exactly after the completion of 34 days of biological onset. Suppose you consult a doctor exactly after 37 days of the biological onset of the disease. Suppose the outcome of the treatment is the cure. What is the duration of the (i)total preclinical phase (ii) detectable pre-clinical phase (iii) clinical phase?

18 Apr 2025
Answer :
Word Count : 506

In epidemiology and clinical trials, understanding the natural history of a disease is crucial for analyzing the progression of disease, timing of interventions, and assessing the effectiveness of diagnostic tests and treatments. The natural history of a disease includes several phases: the total preclinical phase, the detectable pre-clinical phase, and the clinical phase. These phases define the progression of the disease from its biological onset to the point at which symptoms appear, diagnosis is made, and treatment outcomes are assessed.

Total Preclinical Phase: This ___ _________ __________ ___ ________ ________ _____ _____ ______ _____ ___ ________.
_____ __________ _____ _______ __________ ____ _____ ______.
_____ __________ ___ ____ _________ _______ ______ __________ ________ ______ _________ ___.
______ _______ ____ ___ ______ ______ ________ _____ _______ _______ _______ __________.
____ _______ ___ _______ ____ ______.
________ __________ _______ __________ ______ __________.
_________ __________ ________ _______ ____.
_________ ____ _______ _________ ___ _____.
____ ________ ______ ___ ____ ______.
_____ __________ _______ ________ _________ __________ _______ ____.
______ ___ ________ _____ ______ ______ __________ ________.
________ _________ _____ ___ _________ ______.
____ _____ ___ _________ ______ ________ __________ ______.
_____ _________ ___ ______ ____.
______ ________ _____ ______ _____.
____ _________ _____ _______ ___ _______ _______ __________.
_________ ______ ____ _______ ________ __________ ___ ________ ______ _________.
___ ___ ________ ________ ________ _____ __________.
_____ ___ __________ ______ _________ ___.
______ __________ ________ ______ ___ __________ ________.
________ ________ _______ _______ _______ ___.
________ _________ ___ _____ ________ ________ _____ ____ ________ ________ _______.
______ ____ _____ ______ _____ ____ __________ __________ _________ ______ _______.
____ ___ _________ _____ ___ ________ _____ _____ _______ __________ ____.
_______ ___ __________ _______ ____ _________.
____ ________ _______ _____ _______ _________ _______ __________ _____.
_______ _________ ____ ______ __________ _____ ________ _____ _____ _______ ________.
___ __________ _________ ________ __________ _____ _________.
_________ ____ ___ _______ _____ _______ ____ ___ _____.
________ _________ _____ _____ ____ _________ ___ ________.
______ __________ ________ ___ _________ __________ __________ ______ ___ __________ __________ _____.
________ ______ _____ _____ _________ _________ _____ _____ ___ _________ _______.
_____ _________ ______ __________ _____ _____ ____ _____.
___ ___ _________ ____ ___ ________.
_____ ________ ________ _____ ____ _____ ___.
_______ ______ ______ _______ ____ ___ _____ _________ __________.
_________ ___ _____ _____ __________ ______.
_________ ___ ______ __________ _______ ______.
_______ __________ ____ ________ ____ ________.
______ ________ ________ _________ _________ _________.
________ ______ _____ ______ ______ __________ _____ ___ _____ ____ ______.
_______ _________ ___ ___ ______ __________ _____ ________.
_____ ______ ______ ____ _________ ________ ____ _________ _________.
_______ ____ ______ __________ _________ _____ _______ _______.
____ ___ ___ ____ _________.
____ _______ __________ _______ ______ ______ ________ _______ __________ ______ ________.
_________ ____ _________ ___ __________ ___ ___ _____ _______ ______.
________ ______ ___ _____ _____ _____ _____ ______ ______ ____.
_______ __________ ____ __________ ___ __________ ___ _____ ____.
__________ ________ _____ ______ ____ _________ _________ _____ ___ ___ _________.
_________ ______ ______ _________ _________ _______.
__________ _____ __________ ______ _______ __________ ________.
Get Full Answer on WhatsApp

Related Questions

A trial is conducted in which some people with disease X were randomly allocated into two groups. The first group was advised to do some morning walks for 30 minutes and take light food each day and the second group was given one injection and one 100 mg tablet once a day to control disease X. The injection can cause loose motion in some cases and 100 mg tablet has no side effect. At the end of two months, 90% of group I and 80% of group II had recovered from disease X.

i) What are the regimens for group I and group II in this trial?

 

ii) What are the efficacies in group I and group II?

 

iii) What are the safety issues in group I and group II in this trial?

 

If you are told that hemoglobin (Hb) level in blood measures the iron content. The normal level in healthy people is around 15 g/dL. Most Indian women have less and some have even less than 8 g/dL. They are called anemic. Iron supplementation is given to increase this level. Suppose one supplementation increases the mean Hb level in anemics by 3.2 g/dL, after one month of use and the other by 3.6 g/dL, in an equivalence trial on 500 women each. The respective SD's of the of the increases are 0.52 and 0.72 g/dL. The doctors determine that the supplementations can be clinically equivalent if the difference between the increases by the two supplementations does not exceed 0.52 g/dL. Can these two supplementations be considered clinically equivalent at 5% level of significance?

 

Explain the entire procedure of any one of the three study designs (a) Cross Sectional (b) Cohort (c) Case Control.

 

In the natural history of a disease define total preclinical phase, detectable pre-clinical phase and clinical phase. Suppose on 09 am on 25.01.2024 a disease A onset you biologically. Suppose a test of disease A can detect it exactly after the completion of 30 days of biological onset. Suppose signs and symptoms develop exactly after the completion of 34 days of biological onset. Suppose you consult a doctor exactly after 37 days of the biological onset of the disease. Suppose the outcome of the treatment is the cure. What is the duration of the (i)total preclinical phase (ii) detectable pre-clinical phase (iii) clinical phase?

If p denotes proportion and q denotes odds then prove that  Find the range of q. If the odds of smokers in a study are 0.75 then find the proportion of smokers in the study. Assume that each subject of the study is either a smoker or a non-smoker.

IGNOU Solved Assignments Assignments Ignou Projects Project Previous Year Solved Exam Papers Notes Notes Sample Question Papers Sample Question Papers
Login Cart
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★
Top
📞
Call Support Instant phone assistance  In the natural history of a disease define total preclinical
→
🟢
WhatsApp Chat Fast live messaging
→
Email Us Business enquiries & support
→